The store will not work correctly when cookies are disabled.
4-((2,6'-biimidazo[1,2-a]pyridin-3-ylamino)methyl)benzonitrile
ID: ALA4474853
PubChem CID: 155537134
Max Phase: Preclinical
Molecular Formula: C22H16N6
Molecular Weight: 364.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc(CNc2c(-c3ccc4nccn4c3)nc3ccccn23)cc1
Standard InChI: InChI=1S/C22H16N6/c23-13-16-4-6-17(7-5-16)14-25-22-21(26-20-3-1-2-11-28(20)22)18-8-9-19-24-10-12-27(19)15-18/h1-12,15,25H,14H2
Standard InChI Key: GKIQQRHIFTZLFJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
35.6324 -4.4075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4637 -3.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6789 -3.3461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0246 -4.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2401 -4.7106 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0644 -3.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2347 -3.8102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8975 -4.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5189 -5.1295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6708 -5.4473 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.0837 -4.1751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4180 -4.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7536 -4.6623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.4947 -5.4447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0424 -6.0581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8489 -5.8902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1050 -5.1036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5557 -4.4937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0824 -3.3493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.7970 -2.9353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7958 -2.1094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5094 -1.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5085 -0.8726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7920 -0.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0751 -0.8785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0796 -1.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7897 0.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7874 1.1941 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 14 2 0
13 11 1 0
11 12 2 0
12 10 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
11 19 1 0
12 1 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
27 28 3 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.41 | Molecular Weight (Monoisotopic): 364.1436 | AlogP: 4.13 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.42 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.70 | CX LogP: 2.72 | CX LogD: 2.64 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.52 | Np Likeness Score: -2.23 |
References
1. (2018) Inhibitors of trim33 and methods of use, |